Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Medical Molecular Imaging market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Medical Molecular Imaging market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.
Segmented by Category
MRI
CT
PET
SPECT
Ultrasound
Segmented by End User/Segment
Oncology
Cardio and Vascular
Neurology
Others
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Trivitron Healthcare
Toshiba
Siemens
Positron
Philips
Neusoft
Neurologica
Molecular Devices
Mediso
Hitachi
Gvi Medical Devices
GE
Gamma Medica
Digirad
CMR Naviscan
Cardiarc
Biosensors International
BC Technical
Table of Contents1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Medical Molecular Imaging Market Status and Forecast (2016-2027) 1.3.2 Global Medical Molecular Imaging Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis2 Global Medical Molecular Imaging Supply by Company 2.1 Global Medical Molecular Imaging Sales Value by Company 2.2 Medical Molecular Imaging Sales Area of Main Manufacturers 2.3 Trend of Concentration Rate3 Global and Regional Medical Molecular Imaging Market Status by Category 3.1 Medical Molecular Imaging Category Introduction 3.1.1 MRI 3.1.2 CT 3.1.3 PET 3.1.4 SPECT 3.1.5 Ultrasound 3.2 Global Medical Molecular Imaging Market by Category 3.3 North America: by Category 3.4 Europe: by Category 3.5 Asia Pacific: by Category 3.6 Central & South America: by Category 3.7 Middle East & Africa: by Category4 Global and Regional Medical Molecular Imaging Market Status by End User/Segment 4.1 Medical Molecular Imaging Segment by End User/Segment 4.1.1 Oncology 4.1.2 Cardio and Vascular 4.1.3 Neurology 4.1.4 Others 4.2 Global Medical Molecular Imaging Market by End User/Segment 4.3 North America: by End User/Segment 4.4 Europe: by End User/Segment 4.5 Asia Pacific: by End User/Segment 4.6 Central & South America: by End User/Segment 4.7 Middle East & Africa: by End User/Segment5 Global Medical Molecular Imaging Market Status by Region 5.1 Global Medical Molecular Imaging Market by Region 5.2 North America Medical Molecular Imaging Market Status 5.3 Europe Medical Molecular Imaging Market Status 5.4 Asia Pacific Medical Molecular Imaging Market Status 5.5 Central & South America Medical Molecular Imaging Market Status 5.6 Middle East & Africa Medical Molecular Imaging Market Status6 North America Medical Molecular Imaging Market Status 6.1 North America Medical Molecular Imaging Market by Country 6.2 United States 6.3 Canada 6.4 Mexico7 Europe Medical Molecular Imaging Market Status 7.1 Europe Medical Molecular Imaging Market by Country 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain8 Asia Pacific Medical Molecular Imaging Market Status 8.1 Asia Pacific Medical Molecular Imaging Market by Country 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia9 Central & South America Medical Molecular Imaging Market Status 9.1 Central & South America Medical Molecular Imaging Market by Country 9.2 Brazil 9.3 Argentina 9.4 Colombia10 Middle East & Africa Medical Molecular Imaging Market Status 10.1 Middle East & Africa Medical Molecular Imaging Market by Country 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia11 Major Downstream Customers Analysis 11.1 Customer One Analysis 11.2 Customer Two Analysis 11.3 Customer Three Analysis 11.4 Customer Four Analysis12 Global Medical Molecular Imaging Market Forecast by Category and by End User/Segment 12.1 Global Medical Molecular Imaging Sales Value Forecast (2022-2027) 12.2 Global Medical Molecular Imaging Forecast by Category 12.3 Global Medical Molecular Imaging Forecast by End User/Segment13 Global Medical Molecular Imaging Market Forecast by Region/Country 13.1 Global Medical Molecular Imaging Market Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast14 Key Participants Company Information 14.1 Trivitron Healthcare 14.1.1 Company Information 14.1.2 Medical Molecular Imaging Product Introduction 14.1.3 Trivitron Healthcare Medical Molecular Imaging Sales Value, Gross Margin and Global Share (2019-2021) 14.1.4 SWOT Analysis 14.2 Toshiba 14.2.1 Company Information 14.2.2 Medical Molecular Imaging Product Introduction 14.2.3 Toshiba Medical Molecular Imaging Sales Value, Gross Margin and Global Share (2019-2021) 14.2.4 SWOT Analysis 14.3 Siemens 14.3.1 Company Information 14.3.2 Medical Molecular Imaging Product Introduction 14.3.3 Siemens Medical Molecular Imaging Sales Value, Gross Margin and Global Share (2019-2021) 14.3.4 SWOT Analysis 14.4 Positron 14.4.1 Company Information 14.4.2 Medical Molecular Imaging Product Introduction 14.4.3 Positron Medical Molecular Imaging Sales Value, Gross Margin and Global Share (2019-2021) 14.4.4 SWOT Analysis 14.5 Philips 14.5.1 Company Information 14.5.2 Medical Molecular Imaging Product Introduction 14.5.3 Philips Medical Molecular Imaging Sales Value, Gross Margin and Global Share (2019-2021) 14.5.4 SWOT Analysis 14.6 Neusoft 14.6.1 Company Information 14.6.2 Medical Molecular Imaging Product Introduction 14.6.3 Neusoft Medical Molecular Imaging Sales Value, Gross Margin and Global Share (2019-2021) 14.6.4 SWOT Analysis 14.7 Neurologica 14.7.1 Company Information 14.7.2 Medical Molecular Imaging Product Introduction 14.7.3 Neurologica Medical Molecular Imaging Sales Value, Gross Margin and Global Share (2019-2021) 14.7.4 SWOT Analysis 14.8 Molecular Devices 14.8.1 Company Information 14.8.2 Medical Molecular Imaging Product Introduction 14.8.3 Molecular Devices Medical Molecular Imaging Sales Value, Gross Margin and Global Share (2019-2021) 14.8.4 SWOT Analysis 14.9 Mediso 14.9.1 Company Information 14.9.2 Medical Molecular Imaging Product Introduction 14.9.3 Mediso Medical Molecular Imaging Sales Value, Gross Margin and Global Share (2019-2021) 14.9.4 SWOT Analysis 14.10 Hitachi 14.10.1 Company Information 14.10.2 Medical Molecular Imaging Product Introduction 14.10.3 Hitachi Medical Molecular Imaging Sales Value, Gross Margin and Global Share (2019-2021) 14.10.4 SWOT Analysis 14.11 Gvi Medical Devices 14.12 GE 14.13 Gamma Medica 14.14 Digirad 14.15 CMR Naviscan 14.16 Cardiarc 14.17 Biosensors International 14.18 BC Technical15 Conclusion16 Methodology